Literature DB >> 35530826

Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.

Rajaa Jabbouri1, Nouama Bouanani2, Rita Aniq Filali1, Jehanne Aasfara3.   

Abstract

Eosinophilic fasciitis (EF) or Shulman's fasciitis is a rare condition characterized by subcutaneous edematous induration sparing the face and distal extremities and progressing to skin sclerosis. Its association with other pathologies, notably hemopathies, is described in the literature, but its association with smoldering multiple myeloma remains very rare, especially in a younger subject.
Copyright © 2022, Jabbouri et al.

Entities:  

Keywords:  corticosteroids; eosinophilic fasciitis; hemopathy; multiple myeloma; shulman's fasciitis

Year:  2022        PMID: 35530826      PMCID: PMC9076050          DOI: 10.7759/cureus.23896

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  MRI for diagnosis and monitoring of patients with eosinophilic fasciitis.

Authors:  Franz Baumann; Pius Brühlmann; Gustav Andreisek; Beat A Michel; Borut Marincek; Dominik Weishaupt
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

2.  Eosinophilic fasciitis accompanied by serositis.

Authors:  Anastasios Andreopoulos; Tilemachos-Christos Antoniou; Xanthi Yiakoumis; George Andreopoulos; George Vaiopoulos; Kostas Konstantopoulos
Journal:  Isr Med Assoc J       Date:  2009-05       Impact factor: 0.892

3.  Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin.

Authors:  C J Fleming; P Clarke; D Kemmett
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

4.  Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.

Authors:  Masatoshi Jinnin; Toshiyuki Yamamoto; Yoshihide Asano; Osamu Ishikawa; Shinichi Sato; Kazuhiko Takehara; Minoru Hasegawa; Manabu Fujimoto; Hironobu Ihn
Journal:  J Dermatol       Date:  2017-12-13       Impact factor: 4.005

5.  Rheumatoid arthritis with eosinophilic fasciitis and pure red cell aplasia.

Authors:  H M Markusse; F C Breedveld
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

Review 6.  Eosinophilic fasciitis: From pathophysiology to treatment.

Authors:  Hironobu Ihn
Journal:  Allergol Int       Date:  2019-03-22       Impact factor: 5.836

Review 7.  [Eosinophilic fasciitis (Shulman's disease): Diagnostic and therapeutic review].

Authors:  D Sène
Journal:  Rev Med Interne       Date:  2015-09-16       Impact factor: 0.728

8.  Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

Review 9.  Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.

Authors:  Lindsay Bischoff; Chris T Derk
Journal:  Int J Dermatol       Date:  2008-01       Impact factor: 2.736

10.  Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients.

Authors:  Joana Urzal; Miriam Cimbron; Teresa Mendonça; Fátima Farinha
Journal:  Reumatologia       Date:  2019-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.